Advances and critical concerns with the microfluidic enrichments of circulating tumor cells

Kyung A. Hyun, Hyo il Jung

Research output: Contribution to journalReview article

79 Citations (Scopus)

Abstract

Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.

Original languageEnglish
Pages (from-to)45-56
Number of pages12
JournalLab on a Chip
Volume14
Issue number1
DOIs
Publication statusPublished - 2014 Jan 7

Fingerprint

Circulating Neoplastic Cells
Microfluidics
Tumors
Cells
Research
Assays
Single-Cell Analysis
Residual Neoplasm
Neoplasms
Clinical Trials
Blood
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biochemistry
  • Chemistry(all)
  • Biomedical Engineering

Cite this

@article{0d07517a1ff547348759a845178da3ce,
title = "Advances and critical concerns with the microfluidic enrichments of circulating tumor cells",
abstract = "Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.",
author = "Hyun, {Kyung A.} and Jung, {Hyo il}",
year = "2014",
month = "1",
day = "7",
doi = "10.1039/c3lc50582k",
language = "English",
volume = "14",
pages = "45--56",
journal = "Lab on a Chip - Miniaturisation for Chemistry and Biology",
issn = "1473-0197",
publisher = "Royal Society of Chemistry",
number = "1",

}

Advances and critical concerns with the microfluidic enrichments of circulating tumor cells. / Hyun, Kyung A.; Jung, Hyo il.

In: Lab on a Chip, Vol. 14, No. 1, 07.01.2014, p. 45-56.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Advances and critical concerns with the microfluidic enrichments of circulating tumor cells

AU - Hyun, Kyung A.

AU - Jung, Hyo il

PY - 2014/1/7

Y1 - 2014/1/7

N2 - Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.

AB - Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.

UR - http://www.scopus.com/inward/record.url?scp=84889064612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889064612&partnerID=8YFLogxK

U2 - 10.1039/c3lc50582k

DO - 10.1039/c3lc50582k

M3 - Review article

C2 - 23982141

AN - SCOPUS:84889064612

VL - 14

SP - 45

EP - 56

JO - Lab on a Chip - Miniaturisation for Chemistry and Biology

JF - Lab on a Chip - Miniaturisation for Chemistry and Biology

SN - 1473-0197

IS - 1

ER -